Literature DB >> 18706555

Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring.

Britta N Torgrimson1, Jessica R Meendering, Nicole P Miller, Paul F Kaplan, Christopher T Minson.   

Abstract

OBJECTIVE: To assess the effects of the vaginal contraceptive ring cycle on indices of cardiovascular health and risk by studying healthy <span class="Species">women during the active hormone phase compared with the ring-free phase of a standard 21/7-day cycle.
DESIGN: Observational prospective cohort; 4 weeks' duration.
SETTING: Department of Human Physiology, University of Oregon. PATIENT(S): Twenty healthy women. INTERVENTION(S): Endothelial function testing using standard flow-mediated vasodilation of the brachial artery and sublingual nitroglycerin administration. All participants underwent venous blood collection. MAIN OUTCOME MEASURE(S): Endothelium-dependent and endothelium-independent vasodilation of the brachial artery using Doppler ultrasound imaging. Baseline levels of high-density lipoprotein, low-density lipoprotein, triglycerides, total cholesterol, endothelin-1, and fibrinogen. RESULT(S): The active hormone phase of the vaginal ring cycle showed significantly higher vasodilation compared with the ring-free phase. The active hormone phase also showed increased fibrinogen levels compared with the ring-free phase. Low-density lipoprotein lipid levels also fluctuated and were significantly higher during the ring-free phase. CONCLUSION(S): Preliminary study observations of improved endothelial function and lowered low-density lipoprotein levels during the active hormone phase versus the ring-free phase suggest that the vaginal contraceptive ring has beneficial effects on vascular health in women.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706555      PMCID: PMC3012003          DOI: 10.1016/j.fertnstert.2008.06.054

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  54 in total

1.  Modulation of plasma endothelin levels by the menstrual cycle.

Authors:  K H Polderman; C D Stehouwer; G J van Kamp; C G Schalkwijk; L J Gooren
Journal:  Metabolism       Date:  2000-05       Impact factor: 8.694

2.  Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.

Authors:  Mary C Corretti; Todd J Anderson; Emelia J Benjamin; David Celermajer; Francois Charbonneau; Mark A Creager; John Deanfield; Helmut Drexler; Marie Gerhard-Herman; David Herrington; Patrick Vallance; Joseph Vita; Robert Vogel
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

3.  Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII.

Authors:  Marianne van Rooijen; Bo von Schoultz; Angela Silveira; Anders Hamsten; Katarina Bremme
Journal:  Am J Obstet Gynecol       Date:  2002-01       Impact factor: 8.661

4.  Improved analysis of brachial artery ultrasound using a novel edge-detection software system.

Authors:  R J Woodman; D A Playford; G F Watts; C Cheetham; C Reed; R R Taylor; I B Puddey; L J Beilin; V Burke; T A Mori; D Green
Journal:  J Appl Physiol (1985)       Date:  2001-08

5.  Association between wall shear stress and flow-mediated vasodilation in healthy men.

Authors:  A Gnasso; C Carallo; C Irace; M S De Franceschi; P L Mattioli; C Motti; C Cortese
Journal:  Atherosclerosis       Date:  2001-05       Impact factor: 5.162

6.  Occlusion cuff position is an important determinant of the time course and magnitude of human brachial artery flow-mediated dilation.

Authors:  K L Berry; R A Skyrme-Jones; I T Meredith
Journal:  Clin Sci (Lond)       Date:  2000-10       Impact factor: 6.124

7.  Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide.

Authors:  S N Doshi; K K Naka; N Payne; C J Jones; M Ashton; M J Lewis; J Goodfellow
Journal:  Clin Sci (Lond)       Date:  2001-12       Impact factor: 6.124

8.  Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.

Authors:  P M Ridker; M J Stampfer; N Rifai
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

Review 9.  Cholesterol lowering and endothelial function.

Authors:  R A Vogel
Journal:  Am J Med       Date:  1999-11       Impact factor: 4.965

10.  The effect of the menstrual cycle and of ethinylestradiol on nitric oxide, endothelin-1 and homocysteine plasma levels.

Authors:  G S Merki-Feld; B Imthurn; P J Keller
Journal:  Horm Metab Res       Date:  2000-07       Impact factor: 2.936

View more
  2 in total

1.  Short-term oral progesterone administration antagonizes the effect of transdermal estradiol on endothelium-dependent vasodilation in young healthy women.

Authors:  Jennifer A Miner; Emily R Martini; Michael M Smith; Vienna E Brunt; Paul F Kaplan; John R Halliwill; Christopher T Minson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

2.  A combined oral contraceptive containing 30 mcg ethinyl estradiol and 3.0 mg drospirenone does not impair endothelium-dependent vasodilation.

Authors:  Jessica R Meendering; Britta N Torgrimson; Nicole P Miller; Paul F Kaplan; Christopher T Minson
Journal:  Contraception       Date:  2010-04-27       Impact factor: 3.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.